Phillip D. Gray
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Pharmacological Effects and Toxicity Studies
Papers in
-
- Alcohol Consumption and Health Effects 2
- Chemotherapy-induced organ toxicity mitigation 2
-
- Pharmacological Effects and Toxicity Studies 4
- Co-authors
- Keith G. Tolman (8 shared papers)Scott K. Kuwada (4 shared papers)R. Tweedale (1 shared paper)Xiufen Li (2 shared papers)Jinqiu Kuang (2 shared papers)Blair Madison (1 shared paper)Deborah L. Gumucio (1 shared paper)Wade S. Samowitz (1 shared paper)
- Journals
- Biochemical Pharmacology (3 papers)The Journal of Clinical Pharmacology (2 papers)International Journal of Cancer (2 papers)The Journal of Cell Biology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Phillip D. Gray
13 papers receiving 338 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 43
- Pediatrics, Perinatology and Child Health 94
- Immunology and Allergy 22
- Oncology 90
- Biotechnology 28
Countries citing papers authored by Phillip D. Gray
This map shows the geographic impact of Phillip D. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip D. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip D. Gray more than expected).
Fields of papers citing papers by Phillip D. Gray
This network shows the impact of papers produced by Phillip D. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip D. Gray. The network helps show where Phillip D. Gray may publish in the future.
Co-authors
The 25 scholars most cited alongside Phillip D. Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 87 | |
| 2 | 1983 | 61 | |
| 3 | 1978 | 39 | |
| 4 | 2003 | 38 | |
| 5 | 2009 | 33 | |
| 6 | 1984 | 26 | |
| 7 | 1976 | 17 | |
| 8 | Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cells. | 1978 | 16 |
| 9 | 1984 | 11 | |
| 10 | 1994 | 10 | |
| 11 | 2011 | 6 | |
| 12 | 1983 | 6 | |
| 13 | 1989 | 3 |
About Phillip D. Gray
Phillip D. Gray is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, Oncology, Molecular Biology and Epidemiology, having authored 13 papers that have together received 353 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (4 papers), Alcohol Consumption and Health Effects (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Cell Adhesion Molecules Research (2 papers), Liver physiology and pathology (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Epilepsy research and treatment (2 papers). The work is most often cited by research in Pharmacology (43 citations), Pediatrics, Perinatology and Child Health (94 citations), Immunology and Allergy (22 citations), Oncology (90 citations) and Biotechnology (28 citations). Phillip D. Gray has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Keith G. Tolman, Scott K. Kuwada, R. Tweedale, Xiufen Li, Jinqiu Kuang, Blair Madison, Deborah L. Gumucio, Wade S. Samowitz, P.E. Peterson and Samuel P. Hammar. Their work appears in journals such as Biochemical Pharmacology, The Journal of Clinical Pharmacology, International Journal of Cancer, The Journal of Cell Biology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.